Skip to content

Predictive Factors Associated to Bile Cultures and Antibiogram Resistance in Patients with Laparoscopic Cholecystectomy

Predictive Factors Associated with Bile Culture Positivity and PhenotypiCal AntIbiogram Resistance Patterns in Patients Taken to LaparOscopic Cholecystectomy (BACILO): a Protocol for a Prediction Model Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06314399
Acronym
BACILO
Enrollment
703
Registered
2024-03-18
Start date
2024-04-01
Completion date
2024-12-24
Last updated
2025-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Resistant Strain, Biliary Infection

Keywords

biliary infection, bactibilia, antibiotic resistance, laparoscopic cholecystectomy

Brief summary

The BACILO study was designed with the objective of having robust data on local epidemiological bacterial colonisation information on bile cultures with patients taken to laparoscopic cholecystectomy in our institution to find which predictive factors are associated with culture positivity and antibiotic resistance patterns. Secondary endpoints include evaluating demographical, clinical and surgical variables and establishing comparison between both positive and negative bile cultures and between antibiotic sensitive and resistant microorganism strain isolations.

Detailed description

BACILO is single-centre, observational, analytical, prospective study with a prognostic prediction model with the objective of identifying predictive factors associated with microbial and antibiotic resistance patterns in bile cultures of patients taken to laparoscopic cholecystectomy in our institution. Primary outcomes are bile culture positivity and phenotypical resistance antibiogram patterns while secondary outcomes include demographic, clinical and surgical characteristics and surgical outcomes. The main objective is to determine predictive factors using a prediction model, variables included are: Age, diabetes mellitus, C-reactive protein test, choledocholithiasis/ERCP, cholecystitis and severity of cholecystitis according to the 2018 Tokyo guidelines.This in the nature of describing the relationship between bile culture positivity and phenotypical antibiogram resistance patterns in our institution, and establish thus better treatment strategies based on higher quality local evidence.

Interventions

DIAGNOSTIC_TESTBile culture and phenotypic antibiogram resistance test

Extraction of 3-5ml of bile from surgical specimen (gallbladder) to be taken for bacterial culture testing and phenotypical antibiogram resistance if positive

Sponsors

Universidad del Rosario
CollaboratorOTHER
Hospital Universitario Mayor Méderi
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients included must be over 18 years of age and be taken to laparoscopic cholecystectomy between March 2024 and February 2026 in any institution of the Méderi hospital network (Hospital Universitario Mayor and Hospital Universitario Barrios Unidos), have signed the written informed consent to be included in the study and have both bile culture and antibiogram.

Exclusion criteria

* \- Patients that will be taken to laparoscopic cholecystectomy with another concomitant surgical procedure (including but not exclusive to gastrectomy, pancreatoduodenectomy, oesophagectomy, splenectomy, abdominal wall reconstruction, colectomy, amongst others) with the exception of umbilical herniorrhaphy. * Patients without a postoperative control appointment. * Patients with an untreated HIV diagnosis. * Patients with diagnosis of a malignant gallbladder or biliary tract disease documented preoperatively.

Design outcomes

Primary

MeasureTime frameDescription
Bile culture positivityPerioperatively, during the procedure and immediately after the interventionBile culture is tested positive for at least one (1) microorganism
Phenotypical antibiogram resistancePerioperatively, during the procedure and immediately after the interventionIf bile culture is positive, evaluation for possible antibiotic resistance vs sensitivity

Secondary

MeasureTime frameDescription
Demographical and clinical characteristicsPre-interventionTo describe and compare the demographic and clinical characteristics of the study population.
Microbial characteristicsImmediately after the interventionTo describe the microbial characteristics of the bile cultures and their phenotypical antibiogram resistance
Determination of predictive factors (age, diabetes mellitus, choledocholithiasis / ERCP, C-reactive protein, cholecystitis and Tokyo guidelines severity of cholecystitis)Through study completion, around 1 year and a halfTo determine demographic and clinical predictive factors for positive bile cultures and phenotypical antibiogram resistance.
Surgical characteristics and outcomesDuring the 15 day postoperative follow-up appointmentTo describe and compare the surgical characteristics and outcomes of the study population
Bile culture and antibiotic resistance relationshipImmediately after the interventionExplore the relationship between positive bile cultures and phenotypical antibiogram resistance with surgical outcomes

Countries

Colombia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 26, 2026